D S Cooper

Summary

Affiliation: Sinai Hospital of Baltimore
Country: USA

Publications

  1. ncbi request reprint The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial
    Milena Braga
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
    Thyroid 12:135-9. 2002
  2. ncbi request reprint Subclinical thyroid disease: consensus or conundrum?
    David S Cooper
    Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, MD 21204, USA
    Clin Endocrinol (Oxf) 60:410-2. 2004
  3. ncbi request reprint Antithyroid drugs
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore 21215, USA
    N Engl J Med 352:905-17. 2005
  4. ncbi request reprint Approach to the patient with subclinical hyperthyroidism
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, 2435 West Belvedere Avenue, Hoffberger Building, Suite 56, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 92:3-9. 2007
  5. ncbi request reprint Thoughts on prevention of thyroid disease in the United States
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Thyroid 12:925-9. 2002
  6. ncbi request reprint Hyperthyroidism
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, Johns Hopkins University School of Medicine, MD 21215 5271, USA
    Lancet 362:459-68. 2003
  7. ncbi request reprint Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 88:3474-81. 2003
  8. ncbi request reprint Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration
    M Braga
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 86:5148-51. 2001
  9. ncbi request reprint Graves' disease and recurrent ectopic thyroid tissue
    S Basaria
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Thyroid 9:1261-4. 1999
  10. ncbi request reprint Clinical review 129: Oral cholecystographic agents and the thyroid
    M Braga
    Division of Endocrinology and Metabolism, Sinai Hospital, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 86:1853-60. 2001

Collaborators

Detail Information

Publications31

  1. ncbi request reprint The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial
    Milena Braga
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
    Thyroid 12:135-9. 2002
    ..Similar cure rates and time required to achieve hypothyroidism after radioiodine were observed when patients were pretreated with methimazole compared to nonpretreated patients...
  2. ncbi request reprint Subclinical thyroid disease: consensus or conundrum?
    David S Cooper
    Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, MD 21204, USA
    Clin Endocrinol (Oxf) 60:410-2. 2004
  3. ncbi request reprint Antithyroid drugs
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore 21215, USA
    N Engl J Med 352:905-17. 2005
  4. ncbi request reprint Approach to the patient with subclinical hyperthyroidism
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, 2435 West Belvedere Avenue, Hoffberger Building, Suite 56, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 92:3-9. 2007
    ..Nevertheless, it seems reasonable to treat older individuals whose serum TSH levels are less than 0.1 mU/liter and certain high-risk patients, even when the serum TSH is between 0.1 and the lower limit of the normal range...
  5. ncbi request reprint Thoughts on prevention of thyroid disease in the United States
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Thyroid 12:925-9. 2002
    ..Together, these data suggest that the notion of preventive medicine in the United States should be expanded to include thyroid disease as a target for secondary and tertiary intervention...
  6. ncbi request reprint Hyperthyroidism
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, Johns Hopkins University School of Medicine, MD 21215 5271, USA
    Lancet 362:459-68. 2003
    ..The more unusual causes of hyperthyroidism, including struma ovarii, thyrotropin-secreting tumours, choriocarcinoma, and amiodarone-induced thyrotoxicosis are, more often than not, a challenge to diagnose and treat...
  7. ncbi request reprint Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 88:3474-81. 2003
  8. ncbi request reprint Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration
    M Braga
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 86:5148-51. 2001
    ..Based on these cases, and other reports of rapid tumor expansion after rhTSH injection, we recommend glucocorticoid coverage before rhTSH administration for patients with known or suspected neoplasia located in a limited space...
  9. ncbi request reprint Graves' disease and recurrent ectopic thyroid tissue
    S Basaria
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Thyroid 9:1261-4. 1999
    ..It recurred 9 years later when the patient developed Graves' disease. We propose that the recurrence of the ectopic thyroid tissue was due to the influence of thyroid stimulating immunoglobulins (TSI)...
  10. ncbi request reprint Clinical review 129: Oral cholecystographic agents and the thyroid
    M Braga
    Division of Endocrinology and Metabolism, Sinai Hospital, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 86:1853-60. 2001
    ..The lack of significant side effects makes these drugs an excellent short-term option in situations where a rapid clinical improvement is critical...
  11. ncbi request reprint Langerhans cell histiocytosis of the thyroid: a report of two cases and review of the literature
    R J Behrens
    National Cancer Institute, Bethesda, Maryland, USA
    Thyroid 11:697-705. 2001
    ..The first patient also received radiotherapy to his thyroid bed and scalp. We summarize the prior reported cases of LCH involving the thyroid and review the current treatment modalities used for LCH...
  12. pmc Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008
    Ana B Emiliano
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, 1830 East Monument Street, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 95:2227-33. 2010
    ..However, little is known about the rate of use of these drugs and the prescribing practices of physicians treating hyperthyroidism...
  13. ncbi request reprint A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma
    E L Mazzaferri
    Division of Endocrinology, Shands Hospital, Gainesville, Florida 32610, USA
    J Clin Endocrinol Metab 88:1433-41. 2003
    ....
  14. ncbi request reprint A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
    Pamela R Schroeder
    Johns Hopkins Medical Institutions, Division of Endocrinology and Metabolism, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:878-84. 2006
    ..Levothyroxine (L-T4) withdrawal for thyroglobulin measurement and whole body scanning increases these tests' sensitivities but causes hypothyroidism. Recombinant human TSH (rhTSH) enables testing without L-T4 withdrawal...
  15. doi request reprint Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Thyroid 19:1167-214. 2009
    ..Since the publication of the American Thyroid Association's guidelines for the management of these disorders was published in 2006, a large amount of new information has become available, prompting a revision of the guidelines...
  16. ncbi request reprint The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer
    Milena Basaria
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
    Am J Med 112:721-5. 2002
    ..The use of recombinant thyrotropin has fewer adverse effects than does the alternative, which is withdrawal of thyroid hormone replacement, although nausea and headache have been reported. However, recombinant thyrotropin is expensive...
  17. ncbi request reprint Amiodarone and the thyroid
    Shehzad Basaria
    Department of Medicine, Division of Endocrinology, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, Maryland, USA
    Am J Med 118:706-14. 2005
    ....
  18. ncbi request reprint Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer
    Shuiying Hu
    Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:98-104. 2006
    ..Serum DNA methylation markers may potentially be useful in diagnosing thyroid cancer and monitoring its recurrence...
  19. ncbi request reprint TSH suppressive therapy: an overview of long-term clinical consequences
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, USA
    Hormones (Athens) 9:57-9. 2010
    ..g., osteoporosis, cardiovascular disease, diabetes), is uncertain and requires a high degree of clinical experience and judgment...
  20. ncbi request reprint Amyloidosis: role of fine-needle aspiration
    Shehzad Basaria
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Thyroid 13:313-4. 2003
  21. ncbi request reprint Dirty nails
    Hans K Ghayee
    Sinai Hospital, Department of Medicine, 2401 West Belvedere Avenue, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 90:2428. 2005
  22. ncbi request reprint Can amiodarone be restarted after amiodarone-induced thyrotoxicosis?
    Laura E Ryan
    Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University, Columbus, OH, 43210, USA
    Thyroid 14:149-53. 2004
    ..One such case is outlined here and discussed by a panel of experts...
  23. ncbi request reprint Outcomes of patients with differentiated thyroid carcinoma following initial therapy
    Jacqueline Jonklaas
    Georgetown University Medical Center, Washington, DC 20007, USA
    Thyroid 16:1229-42. 2006
    ..We were unable to show any impact, positive or negative, of specific therapies in stage I patients...
  24. ncbi request reprint Combined T4 and T3 therapy--back to the drawing board
    David S Cooper
    JAMA 290:3002-4. 2003
  25. pmc Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials
    Martin A Walter
    Institute of Nuclear Medicine, University Hospital Basel, Switzerland
    BMJ 334:514. 2007
    ..To determine the effect of adjunctive antithyroid drugs on the risk of treatment failure, hypothyroidism, and adverse events after radioiodine treatment...
  26. ncbi request reprint The clinical significance of subclinical thyroid dysfunction
    Bernadette Biondi
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
    Endocr Rev 29:76-131. 2008
    ..Lastly, we address the issue of the need to treat slight thyroid hormone deficiency or excess in relation to the patient's age...
  27. pmc Expanding indications for recombinant human TSH in thyroid cancer
    Bryan R Haugen
    Thyroid 18:687-94. 2008
  28. doi request reprint Review on the occasion of a decade of recombinant human TSH: prospects and novel uses
    Leonidas H Duntas
    Endocrine Unit, Evgenidion Hospital, University of Athens, Medical School, 20 Papadiamantopoulou Street, Athens, Greece
    Thyroid 18:509-16. 2008
    ..Finally, rhTSH may prove to be useful in studying the functional reserve of thyroid in the aging process, as well as the putative role of the TSH receptor in extrathyroidal tissue, such as lymphocytes, osteocytes, and adipocytes...
  29. doi request reprint Thyroxine monotherapy after thyroidectomy: coming full circle
    David S Cooper
    JAMA 299:817-9. 2008
  30. ncbi request reprint Thyroid disease in the oldest old: the exception to the rule
    David S Cooper
    JAMA 292:2651-4. 2004
  31. ncbi request reprint Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    Sinai Hospital of Baltimore and Johns Hopkins University School of Medicine, MD, USA
    Thyroid 16:109-42. 2006